Experts discuss prevalence of insomnia, its co-occurrence with other health conditions, treatment considerations and data with dual orexin receptor antagonists, the newest therapeutic class in the treatment of insomnia. They also emphasize the importance of improving awareness of insomnia and other sleep disorders in various patient populations.
EP. 2: Co-occurrence of Insomnia With Other Health Conditions and Risk Factors and Triggers for InsomniaOctober 31st 2022
Experts review the co-occurrence of insomnia with other medical conditions and discuss risks and triggers that lead to insomnia, such as age and psychiatric conditions.
EP. 7: Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) and Patient Reported OutcomesNovember 21st 2022
Drs Paul Doghramji and Leslie Citrome review the use of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ) to assess treatment efficacy.
EP. 9: Dual Orexin Receptor Antagonists (DORAs) in Treatment of InsomniaNovember 28th 2022
Drs Paul Doghramji and Leslie Citrome provide an overview of dual orexin receptor antagonists (DORAs), suvorexant, lemborexant, and daridorexant, in treatment of insomnia disorder.